TAF6
Transcription initiation factor TFIID subunit 6
Also known as: MGC:8964, TAF2E, TAF6_HUMAN, TAFII70, TAFII80, TAFII85
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49848
- Gene
- TAF6
- Ensembl
- ENSG00000106290
- Chromosome
- 7
- Canonical length
- 677 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the smaller subunits of TFIID that binds weakly to TBP but strongly to TAF1, the largest subunit of TFIID. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
677 residues, UniProt reviewed canonical sequence.
>P49848|TAF6
1 MAEEKKLKLS NTVLPSESMK VVAESMGIAQ IQEETCQLLT DEVSYRIKEI AQDALKFMHM
61 GKRQKLTTSD IDYALKLKNV EPLYGFHAQE FIPFRFASGG GRELYFYEEK EVDLSDIINT
121 PLPRVPLDVC LKAHWLSIEG CQPAIPENPP PAPKEQQKAE ATEPLKSAKP GQEEDGPLKG
181 KGQGATTADG KGKEKKAPPL LEGAPLRLKP RSIHELSVEQ QLYYKEITEA CVGSCEAKRA
241 EALQSIATDP GLYQMLPRFS TFISEGVRVN VVQNNLALLI YLMRMVKALM DNPTLYLEKY
301 VHELIPAVMT CIVSRQLCLR PDVDNHWALR DFAARLVAQI CKHFSTTTNN IQSRITKTFT
361 KSWVDEKTPW TTRYGSIAGL AELGHDVIKT LILPRLQQEG ERIRSVLDGP VLSNIDRIGA
421 DHVQSLLLKH CAPVLAKLRP PPDNQDAYRA EFGSLGPLLC SQVVKARAQA ALQAQQVNRT
481 TLTITQPRPT LTLSQAPQPG PRTPGLLKVP GSIALPVQTL VSARAAAPPQ PSPPPTKFIV
541 MSSSSSAPST QQVLSLSTSA PGSGSTTTSP VTTTVPSVQP IVKLVSTATT APPSTAPSGP
601 GSVQKYIVVS LPPTGEGKGG PTSHPSPVPP PASSPSPLSG SALCGGKQEA GDSPPPAPGT
661 PKANGSQPNS GSPQPAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 35 nTPM
- skeletal muscle: 29 nTPM
- endometrium: 29 nTPM
- blood vessel: 27 nTPM
- colon: 25 nTPM
- cervix: 25 nTPM
Single-cell type
- cytotrophoblasts: 85 nCPM
- late spermatids: 73 nCPM
- migrating cytotrophoblasts: 70 nCPM
- differentiating spermatogonia: 58 nCPM
- undifferentiated spermatogonia: 51 nCPM
- late primary spermatocytes: 47 nCPM
Immune cell
- non-classical monocyte: 28 nTPM
- MAIT T-cell: 18 nTPM
- NK-cell: 16 nTPM
- memory CD8 T-cell: 16 nTPM
- T-reg: 16 nTPM
- gdT-cell: 15 nTPM
Brain region
- cerebral cortex: 42 nTPM
- hippocampal formation: 38 nTPM
- amygdala: 37 nTPM
- basal ganglia: 36 nTPM
- thalamus: 34 nTPM
- hypothalamus: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TAF6.
Disease | AllUniProt
Conditions TAF6 is implicated in, by any mechanism.
- Alazami-Yuan syndrome (ALYUS) MIM:617126
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 226 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Alazami-Yuan syndrome
- Cornelia de Lange syndrome 1
- Inborn genetic diseases
- Gastric cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- -1.41
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- DNA-templated transcription initiation
- mRNA transcription by RNA polymerase II
- negative regulation of cell cycle
- negative regulation of cell population proliferation
- positive regulation of apoptotic process
- positive regulation of DNA-templated transcription
- positive regulation of intrinsic apoptotic signaling pathway
- positive regulation of transcription initiation by RNA polymerase II
- regulation of DNA repair
- regulation of transcription by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- transcription by RNA polymerase II
- transcription initiation at RNA polymerase II promoter
Molecular functions
- aryl hydrocarbon receptor binding
- DNA binding
- protein heterodimerization activity
- RNA polymerase II general transcription initiation factor activity
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TATA box binding protein associated factor (TAF), histone-like fold domain
- Histone-fold
- TAF6, C-terminal HEAT repeat domain
- Armadillo-type fold
- Transcription initiation factor TFIID subunit 6
- TAF6, C-terminal HEAT repeat domain superfamily
- TATA box binding protein associated factor (TAF)
- TAF6 C-terminal HEAT repeat domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TAF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAF6 as an antibody target. Whether an autoantibody or antibody against TAF6 could matter depends on whether native TAF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TAF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...